(0.16%) 5 139.50 points
(0.11%) 38 482 points
(0.22%) 17 885 points
(-0.02%) $83.83
(0.73%) $1.937
(0.26%) $2 353.30
(0.62%) $27.71
(2.21%) $942.45
(-0.20%) $0.933
(-0.35%) $10.99
(-0.33%) $0.798
(1.25%) $93.02
Live Chart Being Loaded With Signals
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies...
Stats | |
---|---|
Šios dienos apimtis | 754 944 |
Vidutinė apimtis | 1.59M |
Rinkos kapitalizacija | 40.37B |
EPS | $0 ( 2024-02-27 ) |
Kita pelno data | ( $1.190 ) 2024-05-28 |
Last Dividend | $0.236 ( 2024-04-01 ) |
Next Dividend | $0 ( N/A ) |
P/E | 33.03 |
ATR14 | $0.0610 (0.04%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-25 | Binns Philip | Sell | 2 827 | Common Stock |
2024-03-15 | Wilson Dow R | Buy | 1 678 | Common Stock |
2024-03-15 | Scangos George A | Buy | 1 678 | Common Stock |
2024-03-15 | Rataj Sue H. | Buy | 1 678 | Common Stock |
2024-03-15 | Podolsky Daniel K | Buy | 410 | Common Stock |
INSIDER POWER |
---|
22.01 |
Last 98 transactions |
Buy: 528 623 | Sell: 330 144 |
Tūris Koreliacija
Agilent Technologies Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
LUMN | 0.929 |
PDS | 0.927 |
ATTO | 0.925 |
ARMK | 0.924 |
DHX | 0.921 |
GMED | 0.917 |
CPRI | 0.917 |
GEO | 0.914 |
WRK | 0.913 |
QGEN | 0.91 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
MSP | -0.926 |
RXN | -0.924 |
MOG-B | -0.923 |
IOT | -0.917 |
TDI | -0.911 |
DCT | -0.902 |
AMAM | -0.898 |
TNK | -0.897 |
KDMN | -0.892 |
AIW | -0.891 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Agilent Technologies Inc Koreliacija - Valiuta/Žaliavos
Agilent Technologies Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $6.83B |
Bruto pelnas: | $3.47B (50.71 %) |
EPS: | $4.22 |
FY | 2023 |
Pajamos: | $6.83B |
Bruto pelnas: | $3.47B (50.71 %) |
EPS: | $4.22 |
FY | 2022 |
Pajamos: | $6.85B |
Bruto pelnas: | $3.72B (54.35 %) |
EPS: | $4.19 |
FY | 2021 |
Pajamos: | $6.32B |
Bruto pelnas: | $3.41B (53.92 %) |
EPS: | $3.98 |
Financial Reports:
No articles found.
Agilent Technologies Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.210 (N/A) |
$0.435 (N/A) |
$0 (N/A) |
$0.450 (N/A) |
$0 (N/A) |
$0.461 (N/A) |
$0 (N/A) |
$0.236 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $1.471 | 2006-11-01 |
Last Dividend | $0.236 | 2024-04-01 |
Next Dividend | $0 | N/A |
Payout Date | 2024-04-24 | |
Next Payout Date | N/A | |
# dividends | 50 | -- |
Total Paid Out | $8.74 | -- |
Avg. Dividend % Per Year | 0.48% | -- |
Score | 4.72 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.20 | |
Div. Directional Score | 8.41 | -- |
Year | Amount | Yield |
---|---|---|
2006 | $1.471 | 6.14% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0.286 | 1.10% |
2013 | $0.352 | 1.17% |
2014 | $0.283 | 0.71% |
2015 | $0.515 | 1.27% |
2016 | $0.477 | 1.17% |
2017 | $0.545 | 1.17% |
2018 | $0.611 | 0.90% |
2019 | $0.672 | 1.02% |
2020 | $0.540 | 0.63% |
2021 | $0.776 | 0.65% |
2022 | $1.065 | 0.68% |
2023 | $0.911 | 0.61% |
2024 | $0.236 | 0.17% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
GOF | Dividend Royal | 2023-11-14 | Monthly | 18 | 8.03% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.184 | 1.500 | 6.33 | 9.49 | [0 - 0.5] |
returnOnAssetsTTM | 0.113 | 1.200 | 6.24 | 7.48 | [0 - 0.3] |
returnOnEquityTTM | 0.212 | 1.500 | 8.76 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.216 | -1.000 | 7.84 | -7.84 | [0 - 1] |
currentRatioTTM | 2.68 | 0.800 | 1.586 | 1.269 | [1 - 3] |
quickRatioTTM | 1.882 | 0.800 | 3.64 | 2.91 | [0.8 - 2.5] |
cashRatioTTM | 1.081 | 1.500 | 5.11 | 7.66 | [0.2 - 2] |
debtRatioTTM | 0.238 | -1.500 | 6.04 | -9.06 | [0 - 0.6] |
interestCoverageTTM | 14.39 | 1.000 | 5.78 | 5.78 | [3 - 30] |
operatingCashFlowPerShareTTM | 6.69 | 2.00 | 7.77 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.63 | 2.00 | 7.19 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.420 | -1.500 | 8.32 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.506 | 1.000 | 4.89 | 4.89 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.197 | 1.000 | 8.07 | 8.07 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.754 | 1.000 | 6.92 | 6.92 | [0.2 - 2] |
assetTurnoverTTM | 0.615 | 0.800 | 9.23 | 7.39 | [0.5 - 2] |
Total Score | 11.63 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 32.65 | 1.000 | 6.80 | 0 | [1 - 100] |
returnOnEquityTTM | 0.212 | 2.50 | 9.20 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.63 | 2.00 | 8.12 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.669 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 6.69 | 2.00 | 7.77 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.216 | 1.500 | 7.84 | -7.84 | [0 - 1] |
pegRatioTTM | -1.031 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.291 | 1.000 | 5.22 | 0 | [0.1 - 0.5] |
Total Score | 5.20 |
Agilent Technologies Inc
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.